Real-time enrollment status for this advanced cancer clinical trial
Current Status
Unknown
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT04983810 |
| Recruiting Status | Unknown |
| Condition | Advanced Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 330 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Cyclacel Pharmaceuticals, Inc. |
| Last Updated on CT.gov | January 25, 2024 (Jan 25, 2024) |
As of March 2, 2026: Clinical trial NCT04983810 is currently unknown participants. This clinical trial study for advanced cancer is not currently accepting new participants at 2 locations across the United States. The study is sponsored by Cyclacel Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT04983810 is currently unknown. The study may resume recruiting in the future.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04983810 was last updated Jan 25, 2024 (January 25, 2024). HelloStudys verifies this status automatically.